Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
about
Production of Se-methylselenocysteine in transgenic plants expressing selenocysteine methyltransferaseSe-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitroDiets high in selenium and isoflavones decrease androgen-regulated gene expression in healthy rat dorsolateral prostateSelenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cellsSurvivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.Molecular and biochemical characterization of the selenocysteine Se-methyltransferase gene and Se-methylselenocysteine synthesis in broccoli.Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cellsSelenomethionine and methyl selenocysteine: multiple-dose pharmacokinetics in selenium-replete men.Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivoAlpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).Methyl selenocysteine: single-dose pharmacokinetics in men.Analysis of Selenium Levels in Osteosarcoma Patients and the Effects of Se-Methylselenocysteine on Osteosarcoma Cells In Vitro.Status of selenium in prostate cancer preventionInfluence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and AlternativeEncapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention.Activation of FOXO1 is critical for the anticancer effect of methylseleninic acid in prostate cancer cells.Selenoproteins reduce susceptibility to DMBA-induced mammary carcinogenesis.Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA.Selenium Biofortification in Radish Enhances Nutritional Quality via Accumulation of Methyl-Selenocysteine and Promotion of Transcripts and Metabolites Related to Glucosinolates, Phenolics, and Amino Acids.Selenoproteins that function in cancer prevention and promotion.Induction of cytokine gene expression in human thyroid epithelial cells irradiated with HZE particles (iron ions).An overview of health-promoting compounds of broccoli (Brassica oleracea var. italica) and the effect of processing.Capabilities of HPLC with APEX-Q nebulisation ICP-MS and ESI MS/MS to compare selenium uptake and speciation of non-malignant with different B cell lymphoma lines.Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin.Se-methyl-L-selenocysteine added as a source of selenium for nutritional purposes to food supplementsElemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice.Selenium speciation analysis of selenium-enriched supplements by HPLC with ultrasonic nebulisation ICP-MS and electrospray MS/MS detection
P2860
Q24797066-7CB61233-5355-4437-83D0-4C2A3034490BQ24813505-E38FF828-849E-4E70-8711-F76AC579301FQ28565580-E0AAAF2F-CA32-471A-AC6B-40357127B502Q30924425-EAB77549-4C5C-4C05-A622-3BD5CE0CEF3CQ30986928-7A5EC321-7AA4-4943-B2D9-FA12D884C976Q33214571-8AFB5F45-8169-440B-899A-C52632B38CD4Q33377810-30B73088-3470-454D-AF36-819E37B1DCD1Q33573583-CE9ED5E2-5CAB-472C-8B9F-846BF37BDABAQ33676981-AED54611-79AC-4F1F-AC69-98755E34ED6EQ33688644-D50BE427-41EE-4C68-8BE2-14363C776980Q33833560-DBE70E53-949E-4288-8DF9-5E523A578904Q33985807-942863D9-100C-4362-B02D-6AB07DA33640Q34276889-CF121F2D-ED7C-439F-86F2-EC8350E6E108Q34336747-0337734E-3360-4160-A904-7895CDD77180Q35529193-A9A8A0F3-59D8-4C55-920A-A4CD4BF2B7E7Q35677178-D2AD829D-04DF-451F-A2EF-B7169EC9EEF1Q35815001-B2BF254B-421E-4DDB-8230-D079A148BD81Q35892045-D5BA1512-8208-4A84-8576-11FBCFE530EFQ35972532-BF1316DB-CAF9-4E93-ABE7-1DB18F2E9FB8Q36336545-331B17DD-03F4-4C4E-8156-FA7C45796548Q36446851-873C46AE-3C20-4CC5-AF20-184086763888Q36611615-D0985AC9-EEC0-4514-A037-2385876C4C46Q37253506-1508E1B5-312F-424B-9AE2-199BC3369020Q37392209-3AC1429D-1E51-4C77-A2A3-05B102D5EFCDQ37467039-4F9BF778-F186-4C7F-A144-1BB0450FCCFBQ38061890-EE1DB1C0-85ED-4478-8839-623D9EA9E126Q39622645-DFF0B48F-511E-4370-966A-4A148A0D5EE0Q39972955-6CC08F38-7921-4A69-A04C-33E74FB1322CQ39987259-31A2E40B-F7A6-4CFD-B609-BD2B07DC35ADQ46598627-F1846663-7D03-42AA-AF1A-31C0EC450414Q47146706-B1B1E8F7-6323-4661-A1FC-82D23443D7D1Q47272648-52CCB0D7-EF9B-41BE-85C8-609A28286CCAQ58213156-053691D2-2070-4D4D-93D7-BD4CDFA50D9B
P2860
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@ast
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@en
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@nl
type
label
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@ast
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@en
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@nl
prefLabel
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@ast
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@en
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@nl
P2093
P356
P1433
P1476
Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.
@en
P2093
P356
10.1207/S15327914NC401_5
P577
2001-01-01T00:00:00Z